Explore every episode of the podcast Diabetic Foot Files

Dr. G explains how type 2 diabetes can develop quietly and describes common but often overlooked early signs — persistent thirst and urination, fatigue, blurry vision, recurrent infections, slow-healing cuts, numbness in the feet, increased hunger, and unexplained weight loss.

The episode also covers how diabetes is diagnosed (A1C, fasting glucose, and glucose tolerance tests), who should be tested, when high blood sugar becomes an emergency, and why regular screening and early detection matter to prevent serious complications.

Dr. G uses the giraffe-in-quicksand metaphor to show how clinical inertia and tunnel vision quietly worsen diabetic foot ulcers. Clinical inertia isn't doing nothing—it’s doing too little: repeating dressings, documenting instead of investigating, or delaying referrals.

She outlines four types of inertia (diagnostic, therapeutic, referral, cognitive), stresses multidisciplinary care, and gives clinical pearls: "stable" ≠ healing, always reassess diagnoses, address blood flow, infection, nutrition, and adherence, and prioritize curiosity, humility, and collaboration to prevent limb loss.

In this episode Dr. G explains how medical necessity and insurance rules affect diabetic foot care, limb salvage, and amputation prevention.

You’ll learn what "medically necessary" really means, how prior authorization and denials work, what to include in an appeal or medical necessity letter, and the clinical consequences of delays.

The episode also highlights health equity—how socioeconomic barriers change access to care—and encourages patients and clinicians to advocate, document clearly, and explore appeal options to protect limbs and lives.

This episode explains what a PICC line is (Peripherally Inserted Central Catheter), how it delivers prolonged antibiotics, and why it is not automatically required for every diabetic foot infection.

Dr. G covers when a PICC makes sense, the importance of source control and multidisciplinary care, the risks and warning signs to watch for, and how patient involvement and infectious disease guidance determine duration and route of therapy.

Dr. G discusses pyomyositis — a deep skeletal muscle infection that can occur in people with diabetes, how it differs from cellulitis, its stages, common causes, typical pathogens, diagnostic steps including MRI and labs, and the importance of source control, imaging, and vascular assessment.

Key takeaways: the visible ulcer may be only the surface of a deeper infection, early recognition and imaging are critical, and management often requires both antibiotics and surgical drainage plus attention to offloading and vascular status.

Dr. G explains pyroptosis — an inflammatory form of programmed cell death driven by inflammasomes, caspase‑1, and gasdermin D — and how its pore‑forming, cytokine‑releasing shutdown can amplify inflammation.

The episode explores how pyroptosis affects keratinocytes, fibroblasts, and macrophages in diabetic foot ulcers, potentially preventing healing by keeping danger signaling active, and why balancing this response matters for recovery.

This episode explains what NPO (nil per os) means, why clinicians use it to reduce aspiration risk during anesthesia or procedures, and why it’s more complex for people with diabetes.

Key points include glucose monitoring every 2–4 hours, tailored insulin and medication plans, risks from gastroparesis, and the importance of asking the care team specific questions about allowed intake and medication adjustments.

Dr. G introduces Peculiar Podiatry with a deep dive into the "purple toe"—a visual clue that can mean anything from a simple bruise to dangerous arterial or venous problems, infection, or neuropathy, especially in people with diabetes.

This episode explains how to evaluate timing, pain, pulses, position changes, and when urgent vascular or emergency care is needed.

Dr. G explores how capsaicin, the active compound in chili peppers, can reduce burning neuropathic pain by overactivating and desensitizing pain-sensing nerves.

The episode explains that capsaicin is not a cure for diabetic neuropathy or a treatment for ulcers, notes differences between low‑dose creams and the 8% prescription patch, and highlights safety precautions (apply only to intact skin, avoid eyes/mucous membranes, and have trained clinicians administer high‑dose patches).

Prediabtes isn’t “ Almost Diabetes” . This episode explains how type 2 diabetes often begins years before diagnosis as prediabetes — a compensatory metabolic state where insulin resistance, pancreatic stress, liver overproduction of glucose, and visceral fat-driven inflammation quietly disrupt glucose control.

You’ll learn the diagnostic thresholds (A1c 5.7–6.4%, fasting glucose 100–125 mg/dL, 2‑hour OGTT 140–199 mg/dL), why different tests can identify different people, who should be tested, and which clinicians to involve (PCP, endocrinologist, dietitian, diabetes prevention programs).

The episode emphasizes prevention: lifestyle-based diabetes prevention programs can reduce progression, metformin is not automatic, and early action can change your metabolic trajectory — protecting overall health and reducing future foot and limb complications.

This episode explains what "stump shrinkage" really means—residual limb volume changes, edema, tissue remodeling, and how different amputation levels affect function and prosthetic fitting.

It outlines practical management steps: compression and dressing strategies, wound and vascular monitoring, prosthetic planning, physical therapy, and the extra vigilance required for people with diabetes to protect the remaining limb and restore mobility.

This episode explores why some diabetic foot ulcers remain inflamed yet fail to clear microbes, distinguishing contamination, colonization, local infection, and clinical infection. It explains how immune dysregulation, neutrophil extracellular traps (NETs), macrophage dysfunction, biofilm, ischemia, hypoxia, neuropathy, and necrotic tissue create an ecosystem that prevents healing.

The episode emphasizes that antibiotics alone are not enough: effective care requires assessing perfusion, offloading, debridement, glycemic and systemic management, targeted antimicrobials when indicated, and ongoing surveillance to change the wound trajectory.

Dr. G discusses realistic expectations for diabetic foot ulcer healing, explaining the medical factors that affect recovery—blood flow, infection control, offloading, nutrition, and time—and why instant results are unlikely.

She contrasts routine wound healing with the emotional and practical challenges of limb salvage, emphasizes tracking progress with measurements and photos, celebrates small victories, and urges patients to seek mental-health support when needed.

In this episode Dr. G explains why tissue adhesives like cyanoacrylates (e.g., Dermabond) work well for clean, superficial, low‑tension wounds but are inappropriate for diabetic foot ulcers. Diabetic ulcers involve neuropathy, poor perfusion, infection risk, dead space, undermining and impaired healing biology that glues cannot fix.

Key takeaways: adhesives only bond superficial skin edges and do not treat infection, necrosis, ischemia or structural problems; using glue can trap drainage and mask deeper issues; tissue glue may last days but is not a cure for complex diabetic wounds.

Dr. G explains what dead space is — a residual tissue cavity after tissue loss or separation in the diabetic foot — why it matters, and how it differs from abscesses, undermining, and tunneling.

He outlines how to recognize dead space (probing, persistent drainage, imaging), its impact on healing, and practical management strategies including debridement, drainage, infection control, offloading, and prevention.

Dr. G explains transepidermal water loss (TEWL) and why a clinically closed diabetic foot ulcer can still have a compromised skin barrier. He outlines how TEWL reflects epidermal function, how diabetes and neuropathy impair skin recovery, and why “functional closure” differs from simple epithelialization.

A multicenter study found higher TEWL at recently closed ulcer sites was linked to increased and earlier recurrence, suggesting TEWL could help guide extended offloading, closer follow‑up, and targeted care to reduce re‑ulceration risk.

Dr. G explores how the tiny nematode C. elegans helps researchers study key processes related to diabetic foot ulcers, including wound detection, calcium signaling, cytoskeletal remodeling, mitochondrial reactive oxygen species, innate immune responses, and bacterial virulence.

While the worm cannot reproduce the full complexity of human diabetic foot disease, its transparency and genetic tractability make it a powerful early-stage model to identify pathways and test hypotheses that could inform future treatments.

This episode explains Erysipelothrix rhusiopathiae, an animal-associated bacterium that can enter through minor skin breaks—often from fish, meat, or livestock exposure—and cause a localized lesion called erysipeloid.

It highlights diagnostic traps in diabetic foot care, the importance of occupational history (remember FISH: Fish exposure, Inoculation, Slowly expanding lesion, Heart involvement), the organism's intrinsic resistance to vancomycin, and the potential for systemic disease including endocarditis.

Dr. G explains why informed consent in diabetic foot care is more than paperwork: it’s a time-sensitive conversation about capacity, risks, alternatives, and what happens if treatment is delayed.

The episode covers capacity versus competency, surrogate and physician consent in emergencies, the emotional weight of amputation decisions, and a four-phase consent model to help patients understand trajectories and make informed choices.

In this episode Dr. G explains how Newton’s laws of motion illuminate why some diabetic foot ulcers heal and others recur. He connects concepts like force, pressure, shear, and ground reaction forces to real-world biomechanics, footwear, and offloading strategies.

The episode focuses on practical takeaways: managing mechanical loading through appropriate offloading devices, understanding patient activity and adherence, and designing prevention plans so healed wounds stay closed.

Your Story Could Save a Limb: Inside the New Diabetic Foot Ulcer Patient Registry

What if the most important piece of diabetic foot ulcer research isn’t another clinical endpoint—but the patient’s story?

In this special episode of LIMBWatch, Dr. G sits down with Dr. Jared Adams, Senior Vice President of Global Medical Affairs, Digital, and Technology at Alira Health, to explore a powerful new approach to diabetic foot ulcer research: building a patient-centered registry that follows the real-world story of people living with DFUs.

A diabetic foot ulcer is never “just a wound.” It can affect mobility, employment, sleep, mental health, independence, finances, transportation, family members, and the ability to access care. Yet many of those experiences never make it into the medical record.

Dr. Adams explains why registries can fill that gap by connecting patient-reported experiences, clinical information, wound images, healthcare records, and eventually claims data to create a much more complete picture of what actually happens to people living with DFUs.

Together, Dr. G and Dr. Adams discuss why clinical trials and real-world evidence serve different purposes, why the patients seen in everyday practice often look very different from carefully selected clinical-trial populations, and how understanding the entire pathway of care may help identify opportunities to intervene before a patient reaches hospitalization, recurrence, or amputation.

One of the most powerful themes of the conversation is co-design. Patients aren’t simply being asked to participate in research—they are being invited to help determine what the research should ask in the first place.

The registry team is currently conducting remote, compensated one-hour interviews with people living with diabetic foot ulcers to learn what researchers may be missing. Participants can share everything from how their ulcer began and how their care was coordinated—or fragmented—to the emotional, financial, and practical realities that don’t appear in a wound measurement.

And compensation matters. As Dr. Adams explains, patients are being compensated because lived experience is expertise. Their time, knowledge, and experiences have value.

These interviews are separate from enrollment in the registry itself. The goal is to listen first, learn from patients, and use those insights to help build a registry capable of following thousands of people over many years.

The conversation also explores the potential of smartphones, AI, remote monitoring, and patient-generated data to become part of the future wound-care toolkit—but with an important reminder: technology cannot replace the human being in the loop.

Perhaps the most important message of the episode is this:

Every toe has a story.

And behind every wound is a person.

If we can capture those stories, connect them to clinical evidence, and understand the pathways that lead toward healing—or toward limb loss—we may be able to move from simply treating diabetic foot ulcers to truly understanding them.

From surveillance before salvage to fragmentation of care, insurance barriers, patient-reported outcomes, quality of life, limb preservation, and the future of real-world evidence, this episode asks a fundamental question:

What could happen if we finally started measuring what matters most to the people living with diabetic foot ulcers?

If you or someone you know is living with a diabetic foot ulcer and would like to learn more about participating in the patient interviews, visit STEADY DFU Patient Registry 

Your story may reveal the question researchers didn’t know they needed to ask.

Your voice matters. And it could help change what happens to the next patient.

Correction: The episode incorrectly stated that US citizenship is required for participation in STEADY. US residency is required, but US citizenship is not required. Citizenship status is not asked or checked. All adult US residents with at least one active diabetic foot ulcer are encouraged to participate. 

 

 

Episode Summary

In this episode of LIMBWatch, we go beyond the wound itself to explore the science, clinical challenges, and innovations shaping the future of limb preservation.

We are joined by the team behind Lavior, including biomedical scientist and Chief Scientific Officer Dr. David Warren, wound care and hyperbaric medicine specialist Dr. Hanley, wound care podiatrist Dr. Sukoff, and National Sales Director Ashlyn Tapley. 

The conversation explores how Lavior was inspired by the healing properties of Inula viscosa, a medicinal plant with centuries of traditional use, and how the company developed a bioengineered hydrogel designed to address key challenges in chronic wound healing.

We dive into the inflammatory phase of wound healing, antimicrobial and anti-inflammatory activity, bioactive compounds, wound-bed preparation, diabetic foot ulcers, surgical wounds, burns, pressure injuries, venous ulcers, and other complex wounds. The discussion also examines how Lavior is being used alongside negative pressure wound therapy, collagen, alginate, skin substitutes, PRP, total contact casting, and other wound-care modalities.

Importantly, this episode goes beyond any single product. We discuss the fundamentals that remain critical to limb preservation: early intervention, vascular assessment and revascularization when necessary, meticulous wound-bed preparation, infection and biofilm management, moisture balance, and—perhaps most importantly—offloading.

The episode also explores where wound care may be headed over the next decade, including new Lavior formulations incorporating collagen and calcium alginate, and the growing need for clinicians who understand chronic wounds and amputation prevention.

And in one of the episode’s most memorable moments, Dr. Hanley shares a powerful message for people living with diabetes:

“You can either have diabetes, or it can have you.”

From the science of chronic inflammation to the human impact of amputation, this episode asks an essential LIMBWatch question:

How early can we intervene—and what can we do differently to preserve the limb before the wound becomes a life-changing event?

Episode Description

Chronic wounds don’t just threaten skin—they can threaten mobility, independence, quality of life, and ultimately the limb.

In this episode of LIMBWatch, we sit down with the Lavior team to explore a different approach to chronic wound healing and limb preservation.

We discuss the science behind Lavior’s Inula viscosa-derived technology, its proposed antimicrobial and anti-inflammatory properties, the role of chronic inflammation in stalled wounds, and how the product is being incorporated into the management of diabetic foot ulcers and other complex wounds.

We also tackle the clinical realities that matter beyond any dressing: early intervention, wound-bed preparation, vascular status, offloading, infection control, and multidisciplinary limb-salvage care.

From diabetic foot ulcers and surgical wounds to ischemic wounds, pressure injuries, burns, and difficult-to-heal wounds, this conversation examines where innovation may fit into modern wound care—and where the fundamentals of limb preservation remain non-negotiable.

Because saving a limb doesn’t start at amputation. It starts much earlier.

🎙️ LIMBWatch | Diabetic Foot Files

This episode is for educational purposes and does not constitute medical advice or an endorsement of any specific product. Clinical decisions should be based on individual patient assessment and the available evidence.

In this episode of Diabetic Fit Files Dr. G explores how the trace element copper affects diabetic foot ulcers at the cellular and molecular level.

Topics include copper's roles in angiogenesis, collagen cross-linking via lysyl oxidase, fibroblast signaling, antimicrobial and anti-biofilm effects, and the promise of controlled copper delivery systems like hydrogels and nanoparticles.

The episode stresses that copper is multifunctional but not a standalone cure: clinical healing depends on addressing vascular, mechanical, and infectious factors as part of a comprehensive limb-salvage approach.

This episode breaks down the neurological exam of the diabetic foot, explaining reflexes, vibration testing, monofilament assessment, proprioception, pinprick and temperature testing, and the autonomic changes that lead to dry skin and fissures.

It shows how different nerve fibers produce paradoxical symptoms, why loss of protective sensation causes silent injuries and ulcers, and why podiatry, vascular assessment and offloading are essential for limb preservation.

This episode explains what to do if you have a diabetic foot ulcer and no health insurance, stressing that you should not ignore the wound or try to self-treat. It covers signs of infection, the need for vascular checks and offloading, and when to seek emergency care.

It also outlines practical options for uninsured patients—community health centers, sliding-fee clinics, hospital charity care—and simple home measures to protect the foot while you arrange professional evaluation.

This episode explores SMAPs — synthetic mimics of antimicrobial peptides — and how they use membrane-targeting chemistry to kill bacteria differently from conventional antibiotics.

It covers the science behind facial amphiphilicity, selectivity versus toxicity, challenges like biofilms and stability, and the potential role of SMAPs as future adjunctive topical therapies for diabetic foot ulcers, while emphasizing they remain experimental and not yet clinical standard of care.

🎙️ Diabetic Foot Files: Limb Watch with Dr. Shilpa Rajan Mulki

What if some amputations could be prevented simply by recognizing the warning signs sooner?

In this episode of Diabetic Foot Files: Limb Watch, Dr. Gabrielle sits down with Dr. Shilpa Rajan Mulki, a diabetologist and diabetic foot and wound-care specialist practicing in Nairobi, Kenya, for a powerful conversation about limb preservation, prevention, and the gaps that can stand between a patient and saving their limb.

Dr. Mulki shares her personal journey into diabetic foot care and explains why multidisciplinary treatment changed the way she approaches complex wounds. Together, they discuss the warning signs of neuropathy and peripheral arterial disease, why so many patients never receive proper foot screening, and how small missed opportunities can eventually lead to devastating complications.

The conversation goes beyond the wound itself—exploring offloading, infection and antibiotic misconceptions, nutrition, biomechanics, skin-tone differences in assessment, referral pathways, healthcare access, telemedicine, clinician education, and the importance of building multidisciplinary teams that actually work together.

Most importantly, this episode asks a bigger question:

Are we doing enough to prevent diabetic foot complications—or are we waiting until the limb is already in danger?

Dr. Mulki message is one every person living with diabetes, caregiver, nurse, physician, and healthcare professional should hear:

Look at your feet. Recognize the warning signs. Act early. Save the limb.

Because limb preservation doesn't begin in the operating room.

It begins with prevention

A man who built a global whiskey empire may have been felled not by drink or duel but by a small foot injury that turned infected. This episode examines the legend of Jack Daniel’s toe, the historical accounts of gangrene and “blood poisoning,” and what modern medicine would call sepsis.

Beyond the mystery, the episode delivers a clear medical lesson: tiny wounds can become life-threatening without prompt podiatric and vascular care. Learn why early attention to foot injuries matters and how today’s treatments could have changed the outcome.

This episode explains undermining in diabetic foot ulcers—how tissue destruction can extend beneath intact skin, why wounds may appear larger after debridement, and what that means for healing.

We cover the causes (pressure, neuropathy, ischemia, infection), clinical clues, why proper assessment and debridement matter, and practical prevention tips like offloading, vascular care, infection control, and good diabetes management.

In this episode Dr. G recounts a surprising barracuda bite that exposes the challenges of marine injuries, especially for people with diabetes. The episode explains how sharp lacerations, contamination from seawater, retained debris, and organisms like Vibrio can turn a beach wound into a serious infection.

Key takeaways include immediate bleeding control and irrigation, careful wound assessment (tendons, bone, foreign bodies, tetanus status), cautious use of closure and targeted antibiotics, and the importance of early medical attention — particularly for patients with neuropathy or impaired healing.

This episode reviews Madura foot (mycetoma), a chronic implantation infection characterized by long-standing swelling, multiple sinus tracts, and visible ‘‘grains.’p>

There are two main types — eumycetoma (fungal) and actinomycetoma (bacterial) — with different treatments (antifungals ± surgery vs prolonged antibiotics). Diagnosis relies on deep tissue sampling, culture, histology and imaging to define extent. Early recognition, protective footwear, and daily foot checks are key to limb preservation, especially in patients with diabetes and neuropathy.

Welcome to LIMBWatch — the global movement dedicated to protecting limbs, preventing amputations, and transforming the future of diabetic foot care.

In this landmark episode, we welcome one of the world’s most influential leaders in diabetes and diabetic foot disease — Dr. Andrew Boulton, a pioneer whose research, leadership, and advocacy have shaped modern approaches to neuropathy, diabetic foot screening, and limb salvage.

With more than 600 peer-reviewed publications, an H-index exceeding 130, and decades of international leadership including roles with global diabetes organizations, Dr. Boulton shares lessons from a lifetime dedicated to one mission: preventing unnecessary amputations and improving the lives of people living with diabetes worldwide.

In this powerful conversation, Dr. Boulton discusses:

🦶 Why diabetic neuropathy can remain silent until it is too late 🦶 The life-changing importance of annual diabetic foot screening 🦶 Why “take off the shoes and socks and look at the feet” remains one of the most powerful tools in medicine 🦶 The misconception that amputation is an inevitable outcome of diabetic foot disease 🦶 How multidisciplinary foot teams can transform limb salvage outcomes 🦶 Why prevention must become the future of diabetic foot care 🦶 The role of AI and technology in identifying high-risk patients 🦶 Why evidence-based medicine is essential for advancing wound healing treatments 🦶 The overlooked importance of footwear, offloading, biomechanics, and patient-centered care 🦶 The future of global diabetic foot initiatives and making limb preservation accessible everywhere

Dr. Boulton also shares personal reflections from his career, including lessons learned from patients, his admiration for pioneers like Dr. Paul Brand, and why the greatest reward in medicine is not financial success — but the ability to change lives.

His message is clear:

Diabetic foot complications are preventable. Screening saves limbs. Early intervention saves lives.

This episode is a must-listen for healthcare professionals, patients, researchers, policymakers, and anyone committed to building a future where amputations become less common and limb salvage becomes the global standard.

This is LIMBWatch — because every limb matters.

This episode clarifies the difference between antimicrobials (agents that act against a range of microorganisms) and antibiotics (drugs that specifically target bacteria), and explains related terms like antiseptics, contamination, colonization, and infection in diabetic foot ulcers.

Dr. G reviews when topical antimicrobial dressings are appropriate, why they do not automatically replace systemic antibiotics, and how debridement, source control, and wound biology guide treatment decisions.

Key takeaways focus on evaluating the wound, understanding product mechanisms, avoiding unnecessary antibiotics through stewardship, and choosing interventions that help heal the patient and protect the limb.

This episode explains why healed wounds can feel tight, covering the stages of wound healing, the role of myofibroblasts and alpha-SMA in wound contraction, and how scar tissue differs from normal skin.

It discusses how diabetes alters healing, the long remodeling phase (months to over a year), practical care tips like moisturization and follow-up, and warning signs that require prompt medical attention.

This episode explores Rhodococcus equi — a pink, soil‑associated bacterium historically linked to horses that can survive inside macrophages and mimic tuberculosis in the lungs.

Dr. G discusses its discovery, how humans become exposed, diagnostic clues (culture, MALDI‑TOF, PCR), challenges in treatment (intracellular survival, prolonged combination antibiotics, and need for surgical source control), and its importance in immunocompromised and diabetic foot wound patients.

This episode traces the history and science behind triple antibiotic ointment—its three ingredients (bacitracin, neomycin, polymyxin B), how they attack different bacteria, and why it became a household staple for minor cuts.

It explains why diabetic foot ulcers are fundamentally different from everyday wounds—driven by neuropathy, poor blood flow, chronic inflammation, biofilm, and deeper infection—and why a topical ointment cannot address these underlying problems.

The episode also covers risks of using ointment on diabetic ulcers (maceration, contact dermatitis, altered wound microbiome), the difference between colonization and infection, and the importance of prompt medical assessment, vascular evaluation, offloading, debridement, glucose control, and specialized wound care.

Episode Title: The 10-Gram Test That Can Save a Limb: Understanding Monofilament Screening, Neuropathy & Prevention with Dr. Thomas Hardiman

Episode Summary:

What if one of the simplest tools in diabetic foot care could help prevent devastating complications before they happen?

In this powerful episode of LIMBWatch on Diabetic Foot Files, Dr. Gabrielle Donaldson sits down with Dr. Thomas Hardiman, a podiatric surgeon with over 40 years of experience in foot and ankle care and a pioneer in diabetic foot screening through his work with medical monofilament technology.

Together, they take a deep dive into the science, history, and clinical importance of the 10-gram monofilament examination — a simple yet powerful tool used to identify loss of protective sensation (LOPS) and help recognize patients at risk for diabetic foot ulcers and amputations.

Dr. Hardiman reveals the fascinating story behind the development of the monofilament, from early sensory testing pioneers to the influence of Dr. Paul Brand’s groundbreaking work, and explains why prevention starts by “going upstream” rather than waiting until patients present with wounds.

In this episode, you’ll learn:

🦶 How the 10-gram monofilament actually works and what is happening at the nerve level when sensation is lost 🧬 How chronic hyperglycemia damages nerves through metabolic pathways, myelin injury, and impaired sensory signaling ⚠️ Why neuropathy is not simply “numbness” — but the loss of the body’s protective alarm system 🔍 Why a patient can have a normal monofilament exam and still remain at risk for ulceration 🎵 The difference between monofilament testing, vibration perception testing, and tuning fork examinations 📋 The correct technique, anatomical testing sites, and common mistakes clinicians make 🦠 Why single-use monofilaments matter for accuracy and infection prevention 👟 The importance of examining footwear and how a hidden foreign object can lead to a recurring ulcer 🤖 How artificial intelligence may transform diabetic foot surveillance and help identify high-risk patients earlier ❤️ Why patient education, daily foot inspections, and prevention remain some of the most powerful limb-saving interventions

Dr. Hardiman shares unforgettable clinical lessons, including a patient whose heel ulcer repeatedly returned because a nail hidden inside his shoe was causing repeated trauma — a reminder that sometimes the most important diagnostic tools are simply looking, listening, and paying attention.

He also challenges the healthcare community to rethink the phrase “silent epidemic,” explaining why diabetic foot complications are not silent and why calling them that may unintentionally create acceptance instead of urgency.

His message to patients is clear:

“Your feet should last a lifetime, and with proper care, they can.”

This episode is a reminder that limb preservation does not always begin with the newest technology. Sometimes it begins with mastering the fundamentals, performing them consistently, and empowering patients before the first ulcer ever develops.

Join us for an eye-opening conversation about neuropathy, prevention, screening, and the simple test that can help change the future of diabetic limb health.

Key Takeaway Quote: “We don’t sell monofilaments. We partner in prevention.” — Dr. Thomas Hardiman

🦶 A 10-gram filament can change the future of a limb.

Before a diabetic foot ulcer appears, there may be a silent warning sign: loss of protective sensation.

Dr. Hardiman, Medical Director of Medical Monofilament, explains why proper monofilament testing matters — helping clinicians identify the “foot at risk” and take action before a small problem becomes a devastating complication.

The right tool. The right technique. The right time.

Learn more about Medical Monofilament technology: 🔗 https://www.medicalmonofilament.com

 

 

This episode explores why pain evolved as a critical protective alarm and how diabetes—through chronic high glucose, inflammation, and microvascular damage—silences that alarm by injuring peripheral nerves.

It explains the biological pathways behind diabetic neuropathy, why the feet are especially vulnerable, how repetitive pressure and biofilm-forming bacteria turn painless injuries into ulcers, and the stepwise cascade from nerve damage to amputation.

The episode emphasizes prevention and the clinician’s role as an external warning system: early screening, offloading, proper footwear, glucose control, vascular assessment and coordinated limb-salvage care to protect patients’ feet.

This episode explains gossypiboma (retained surgical sponge), how the body mounts a foreign‑body granuloma response, and why these sponges can mimic infection or tumors and lead to chronic inflammation.

It highlights the added danger for people with diabetes (impaired immunity, poor circulation, neuropathy), shares a real diagnostic case, and reviews prevention steps like sponge counts, radiopaque markers, barcode systems, and surgical timeouts. The key message: persistent non‑healing wounds often need a detective approach to look beneath the surface.

Melioidosis is an infection caused by the soil and water bacterium Burkholderia pseudomallei that can enter through cuts, wounds, or inhalation. It often mimics common conditions—pneumonia, tuberculosis, routine wound infections, or chronic diabetic foot infections—making diagnosis challenging.

People with diabetes are at higher risk, and proper diagnosis requires culture and targeted therapy (IV intensive antibiotics such as ceftazidime or meropenem followed by prolonged oral eradication therapy). Prevention focuses on reducing soil and water exposure, protective footwear, wound care, and detailed environmental history for at-risk patients.

The below-the-knee amputation (BKA) is a common major limb loss in people with diabetes, resulting from a long pathway of neuropathy, vascular disease, biomechanical breakdown, ulcers, and infection. Modern amputation philosophy focuses on preserving the knee to maximize function, but BKA remains a marker of advanced systemic disease with significant morbidity and mortality.

Preserving the knee improves mobility, energy efficiency, and prosthetic outcomes; yet prevention is crucial. Early screening, offloading, wound care, vascular assessment, and multidisciplinary limb-salvage teams—especially podiatrists working with vascular and infectious disease specialists—are key to stopping the progression that leads to amputation.

LIMBWatch Series | Dr. Paula DeJesus DPM, FACFAS, : The Future of Limb Salvage Through Minimally Invasive Surgery In this episode of the LIMBWatch Series on Diabetic Foot Files  sits with Dr. Lady Paula DeJesus DPM, FACFAS, DABPM, CWSP— a triple board‑certified podiatric surgeon and Section Chief at Yale New Haven Health Greenwich Hospital Dr. Dejesus shares her remarkable journey into podiatric medicine and discusses the clinical decision-making behind complex diabetic foot infections, osteomyelitis, peripheral arterial disease, and limb preservation. She explains how minimally invasive surgical techniques are transforming diabetic limb salvage, including innovative approaches to treating calcaneal osteomyelitis while avoiding major amputations such as minimally invasive techniques like Avedis suction curettage. The conversation also explores the importance of multidisciplinary care, early vascular assessment, biomechanics, patient compliance, advanced imaging, regenerative medicine, and the compassionate communication needed to help patients understand amputation risk without losing hope. Whether you’re a podiatrist, wound care clinician, vascular specialist, student, or simply passionate about preventing amputations, this episode is filled with practical clinical pearls and inspiring insights from one of today’s leaders in limb salvage. In this episode you’ll learn: When to escalate from conservative care to surgery The role of vascular assessment in limb preservation Why biomechanics is often the missing piece in wound healing Modern approaches to diabetic foot osteomyelitis How minimally invasive surgery is changing limb salvage The value of multidisciplinary teams in reducing amputations Strategies for improving patient compliance and communication Clinical lessons every young limb salvage specialist should know In this episode of Limb Watch, — shares real-world limb preservation strategies, including skin substitutes, and the importance of revascularization for diabetic foot infections. Diabetic Foot Files is dedicated to advancing diabetic foot care, wound healing, and amputation prevention through conversations with world-renowned experts in limb salvage.

Dr. G examines how diabetic toes and ulcers are rarely just wounds but visible warnings of neuropathy, poor circulation, infection, and gaps in care. She asks who is responsible for protecting the foot — the patient, primary care, podiatry, vascular, infectious disease, surgery, or nursing — and how fragmented referrals and delayed access can lead to a cascade ending in amputation.

The episode also explains hospital handling of amputated tissue, patients’ rights to their removed parts, and the future of limb preservation through surveillance technologies and coordinated responsibility to prevent avoidable loss.

This episode introduces edge trenching, a novel debridement technique developed by Dr. Igor Melnichuk that targets dysfunctional wound edges (epibolies, hyperkeratosis, rolled or fibrotic margins) to create a biologically active transition zone and promote epithelial migration.

It explains the procedure, proposed mechanisms, clinical use—especially in diabetic plantar ulcers—how trenches are created and repeated, and emphasizes that edge trenching must be part of comprehensive care addressing perfusion, infection control, offloading, and underlying causes.

Dr. Giulia Baldazzi, a vascular surgeon, fellow and phd candidate researcher, shares her journey from UCSF to Italy and explores advances in perfusion assessment, revascularization, and limb preservation for diabetic foot care.

She discusses diagnostic innovations (PAT, MaxCORE, NIRS), the importance of early vascular referral and multidisciplinary teams, and practical strategies to prevent amputations and improve healing.

Actinomycosis is a rare, slow-growing filamentous gram-positive bacterial infection that can mimic cancer, tuberculosis, or chronic diabetic foot infections by producing woody fibrosis, interconnected sinus tracts, and characteristic yellow "sulfur" granules.

Diagnosis requires deep tissue biopsy and careful anaerobic culture or histology; treatment is prolonged high‑dose penicillin (or alternatives if allergic) often combined with surgical drainage and debridement.

In this episode of Diabetics with Files, Dr. G explains liquid biopsies — blood tests that detect cell-free DNA and other molecular signals — and how they work.

We explore how this technology could help detect infection early, identify harmful inflammation, predict a wound’s healing potential, and personalize treatment for diabetic foot ulcers.

The episode also covers current limitations — cost, access, standardization, and need for clinical validation — and explains that liquid biopsies would complement, not replace, clinical exams and imaging.

Ultimately, liquid biopsies could shift wound care from reactive to predictive and improve limb salvage in the future.

This episode explains how chronic wounds—especially heavily exudative and diabetic ulcers—act like metabolic drains, leaking proteins, growth factors, immune cells, electrolytes, and calories and impairing the body’ s ability to heal.

Listen for signs of protein loss (low albumin, persistent drainage, weight/muscle loss, delayed healing) and practical strategies to fight back: infection control, offloading, appropriate compression, nutrition optimization, and closing the wound to stop the ongoing resource loss.

LIMBWatch | Dr. David B. Alper – The Policy Behind Preventing Amputations

Why are so many lower extremity amputations still happening when the majority could be prevented?

In this powerful episode of LIMBWatch, Dr. Gabrielle Hutcheson sits down with nationally recognized limb preservation advocate Dr. David B. Alper, DPM, to explore the critical intersection of healthcare policy, reimbursement, advocacy, and limb salvage. Drawing on decades of clinical experience and legislative leadership, Dr. Alper explains why preventing amputations requires more than excellent medicine—it requires changing the healthcare system itself.

Together, they discuss the barriers clinicians face in obtaining early diagnostic testing, advanced wound care therapies, diabetic footwear, vascular imaging, and emerging technologies that could dramatically reduce limb loss. Dr. Alper also shares ongoing legislative efforts to improve access to care, simplify insurance requirements, expand diabetic foot protection programs, and strengthen multidisciplinary collaboration.

The conversation highlights the importance of early detection of peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI), the role of advocacy organizations, and why clinicians, patients, and policymakers must work together to shift healthcare from reacting to amputations toward preventing them.

In this episode, you'll learn:

• Why an estimated 85% of diabetic-related amputations may be preventable

• The policy barriers limiting early PAD and CLTI diagnosis

• How insurance reimbursement influences limb salvage decisions

• Why diabetic footwear, vascular imaging, and preventative screening remain underutilized

• The importance of multidisciplinary limb preservation teams

• How clinicians and patients can become advocates for legislative change

• Practical clinical pearls for identifying high-risk patients before limb loss occurs

Whether you're a podiatrist, vascular specialist, wound care clinician, primary care provider, healthcare administrator, policymaker, or patient advocate, this episode offers valuable insight into how policy decisions directly impact patient outcomes—and what can be done to change the future of limb preservation.

Because saving limbs starts long before the operating room—it starts with education, early intervention, and advocacy.

 

In this episode , one of the world’s most influential pioneers in limb preservation, Dr.David Armstrong DPM, MD, PhD Distinguished Professor of Surgery and Neurological Surgery and a Global Leader in limb preservation whose research has fundamentally changed how clinicians approach diabetic foot disease.

Dr. Armstrong shares the personal story that inspired his lifelong mission to prevent amputations, describing two unforgettable patients whose experiences taught him one of medicine’s greatest lessons—that the absence of pain can be more dangerous than pain itself.

Throughout the conversation, he explains why diabetic foot ulcers remain one of the most underestimated complications of diabetes, introduces the revolutionary concept of diabetic foot remission, and discusses why healing an ulcer is only the beginning of lifelong prevention.

Listeners will discover:

• Why diabetic foot ulcers are a “silent and sinister syndrome”
• The true meaning of diabetic foot remission and why recurrence is expected rather than failure
• How annual foot screening could prevent countless amputations worldwide
• Why multidisciplinary limb preservation teams reduce both amputations and mortality
• The biggest unanswered questions surrounding diabetic foot infection
• The future of wearable technology, smart insoles, smart socks, smart scales, and AI-powered home monitoring
• How underserved communities can dramatically improve limb salvage with collaboration rather than expensive technology
• Why the future of diabetic foot care depends on teamwork, innovation, and earlier intervention

Dr. Armstrong also reflects on the evolution of limb preservation over the past three decades, discusses the rapid advances in digital health and remote monitoring, and shares his vision of a future where preventable diabetic amputations become increasingly rare.

Whether you’re a podiatrist, vascular surgeon, wound care specialist, endocrinologist, nurse, therapist, researcher, student, or someone living with diabetes, this conversation offers invaluable insights from one of the architects of modern diabetic limb salvage.

 

Key Takeaway:

“Find a friend.” According to Dr. Armstrong, preventing amputations isn’t the work of one specialty—it takes interdisciplinary teams united by one mission: keeping patients walking and living healthier lives.